Drug Target Review2025-01-06T08:00:51
Huntsman Cancer Institute researchers have identified a gene variant in Andean populations that could predict blood cancer treatment outcomes and potentially lead to targeted therapies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-09-10T08:41:00Z
Sponsored by DNA Genotek Inc.
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2026-08-26T07:00:00
Contributor Professor Paul O’Reilly, Drug Target Review
2026-10-07T14:00:00
Sponsored by WuXi AppTec
2026-06-29T06:49:00
Contributor Laura Alvarez, Drug Target Review
2024-02-01T11:52:50
Sponsored by Leica Microsystems
Site powered by Webvision Cloud